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IN TRO DUC TION
Patch test (epicutaneous) is a gold stan dard for
the di ag no sis of al ler gic con tact der ma ti tis. The di -
ag no sis is not usu ally ap par ent from his tory or phy -
s i cal ex am i na tion, and with out patch test ing it is im -
pos si ble to de lin eate the un der ly ing al ler gen (1). An 
early di ag no sis has been re ported to im prove re -
sponse to treat ment (2,3). Sev eral stud ies have as -
sessed the reproducibility of dif fer ent patch test
sys tems with dif fer ent re sults (4-12). The most pre -
v a lent al ler gens showed great vari abil ity from study
to study (4,13). We em barked upon this study to
shed more light upon the ep i de mi ol ogy on con tact
al lergy in Croatia. This study of con tact al lergy was
so de signed as to re as sess the reproducibility of
patch test ing in con cor dance with clin i cal di ag no -
ses and phys i cal ex am i na tion. In our pre vi ous stud -
ies we have de picted nickel and neomycin as fre -
quent con tact al ler gens (4,12). We recommend
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SUM MARY Epicutaneous (patch) test is a stan dard test to con firm con tact
al lergy. Dur ing a six-year pe riod (1998-2003), con tact al ler gic der ma ti tis
was di ag nosed in 4132 (65%) of 6341 pa tients us ing stan dard patch test
with a Cro atian se ries of al ler gens ac cord ing to the In ter na tional Con tact
Der ma ti tis Re search Group (ICDRG). The most com mon clin i cal di ag no ses 
re lated to con tact al lergy (male; fe male) were con tact al ler gic der ma ti tis
(65.4%; 72.2%); atopic der ma ti tis (15.9%; 11.7%); con tact ir ri tant der ma ti tis 
(7.0%; 6.6%) and nummular eczematoid der ma ti tis (4.2%; 2.4%). Ac cord -
ing to oc cu pa tion, pos i tive patch test re ac tion was most com monly ob -
served in work ers, whereas 65% of pa tients showed pos i tive re ac tions to
one or more sub stances. There was an in creased fre quency of pos i tive
patch test re ac tions to po tas sium dichromate, nickel sul fate, thimerosal and 
neomycine sul fate, along with a sig nif i cant de crease in the fre quency of
pos i tive patch test re ac tions to co balt chlo ride, carba mix, wood tars, de ter -
gents, parabens mix ture, urushiol and rub ber mix ture. We strongly rec om -
mend keep ing up-to-date with the ep i de mi ol ogy of con tact al lergy in Croatia. 
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keeping up-to-date with the epidemiology of de lay -
ed hypersensitivity. 
PA TIENTS AND METH ODS 
The study was car ried out at Al lergy Clinic, De -
part ment of Der ma tol ogy and Venero logy, Zagreb
Uni ver sity Hos pi tal Cen ter, Zagreb, Croatia. We re -
viewed med i cal re cords of 4132 pa tients with pos i -
tive re sults of patch test ing dur ing the pe riod from
1998 to 2003. There were 2940 (71.2%) fe male and 
1192 (28.8%) male pa tients, me dian age 40 years,
with dif fer ent clin i cal di ag no ses (male; fe male):
con tact al ler gic der ma ti tis (65.4%; 72.2%); atopic
der ma ti tis (15.9%; 11.7%); con tact ir ri tant der ma ti -
tis (7.0%; 6.6%); nummular eczematoid der ma ti tis
(4.2%; 2.4%); pso ri a sis vulgaris (2.9%; 0.6%);
seborrheic der ma ti tis (0.9%; 1.1%); stomatitis
(0.1%; 0.6%); pru ri tus sim plex (0.9%; 0.6%);
vasculitis (0.4; 0.4%); other in flam ma tory derma -
toses (0.3%; 0.7%), and other (1.8%; 3.1%) (Ta ble
1). De tails on age, sex, pre sent ing com plaint, his -
tory of al lergy, clin i cal di ag no ses and oc cu pa tional
his tory are pre sented in Ta ble 2. There were 645
(15.6%) stu dents, 1342 (32.5%) work ers, 325
(7.9%) med i cal and al lied pro fes sions, 892 (21.6%)
of fice work ers, 233 (5.6%) house wives, 505
(12.2%) pen sion ers and 190 (4.6%) oth ers (Ta ble
2). We in cluded pa tients sus pected to have al ler gic
con tact der ma ti tis based on clin i cal grounds and
who had un der gone patch test ing with a Cro atian
stan dard patch test se ries of al ler gens (Ta ble 3).
We ex cluded pa tients who re ceived top i cal or sys -
temic ste roids, immuno sup pres sive drugs or those
suf fer ing from chronic ill nesses. The stan dard
patch test bat tery al ler gens were tested on the up -
per back. Us ing a stan dard tech nique with
Beiersdorf scanpor tape ac cord ing to the In ter na -
tional Con tact Der ma ti tis Re search Group
(ICDRG), the test was read at 48 and 72 hours
(14,15). Test re sults were in ter preted us ing the fol -
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Ta ble 1. Clin i cal di ag no ses in re la tion to pos i tive patch test re ac tion 1998-2003*
Year         1998         1999             2000           2001           2002           2003             TOTAL
Sex      M     F       M        F        M       F       M      F      M      F       M      F       M         F
   234    602     235      498      176     463     194    542     181    422     172    413    1192    2940
Diagnosis (N)   n   %   n   %   n   %   n   %   n   %   n   %   n   %   n  %   n  %  no   %  no   %  no   %  no  %  no   %
CAD 135 57.7 445 73.9 145 61.7 349 70.1 116 65.9 326 70.4 126 64.9 379 69.9 130 71.8 317 75.1 128 74.4 308 74.6 780 65.4 2124 72.2
CD  19  8.1  42  7.0  18  7.7  36  7.2  14  8.0  28  6.0  12  6.2  35  6.5   7  3.9  25  5.9  13  7.6  27  6.5  83  7.0 193  6.6
AD  48 20.5  64 10.6  38 16.2  65 13.1  29 16.5  57 12.3  36 18.6  82 15.1  24 13.3  39  9.2  15  8.7  37  9.0 190 15.9 344 11.7
DEN   7  3.0  14  2.3   8  3.4   9  1.8   6  3.4   9  1.9   9  4.6  16  3.0  11  6.1  14  3.3   9  5.2  10  2.4  50  4.2  72  2.4
Psoriasis vulgaris  12  5.1   4  0.7  13  5.5   5  1.0   5  2.8   5  1.1   2  1.0   3  0.6   0  0.0   0  0.0   3  1.7   1  0.2  35  2.9  18  0.6
Seborrheic
 dermatitis   1  0.4   5  0.8   1  0.4   7  1.4   3  1.7   7  1.5   2  1.0   0  0.0   3  1.7   8  1.9   1  0.6   4  1.0  11  0.9  31  1.1
Stomatitis   0  0.0   2  0.3   0  0.0   3  0.6   0  0.0   4  0.9   0  0.0   2  0.4   1  0.6   2  0.5   0  0.0   6  1.5   1  0.1  19  0.6
Pruritus simplex   5  2.1   4  0.7   5  2.1   1  0.2   0  0.0   4  0.9   1  0.5   3  0.6   0  0.0   1  0.2   0  0.0   4  1.0  11  0.9  17  0.6
Vasculitis   1  0.4   3  0.5   2  0.9   5  1.0   1  0.6   1  0.2   0  0.0   2  0.4   0  0.0   0  0.0   1  0.6   0  0.0   5  0.4  11  0.4
Other
 inflammatory
 dermatoses   1  0.4   8  1.3   1  0.4   9  1.8   0  0.0   1  0.2   2  1.0   1  0.2   0  0.0   0  0.0   0  0.0   1  0.2   4  0.3  20  0.7
Other    5  2.1  11  1.8   4  1.7   9  1.8   2  1.1  21  4.5   4  2.1  19  3.5   5  2.8  16  3.8   2  1.2  15  3.6  22  1.8  91  3.1
*Abbreviations: M=male; F=female; CAD=contact allergic dermatitis; CD=contact irritant dermatitis; AD=atopic dermatitis; DEN=dermatitis eczematoides
nummularis
Ta ble 2. Sub jects with pos i tive patch test re ac tion
ac cord ing to oc cu pa tion
Year 1998 - 2003
Sex Male Female
N 1192 2940
Occupation n % n %
Students  273  22.90  372  12.65
Workers  249  20.89 1093  37.18
Medical and related professions   71   5.96  254   8.64
Office workers  225  18.88  667  22.69
Housewives    0   0.00  233   7.93
Pensioners  296  24.83  209   7.11
Others   78   6.54  112   3.81
Total 1192 100.00 2940 100.00
low ing scale: neg a tive re ac tion (0); macular er y -
thema (?); er y thema/in fil tra tion and pos si bly pa pu -
les (1+); erythematous papules and/or ves i cles
(2+); spread ing blis ters and/or crust with ul cer ation
(3+); and ir ri tant re ac tion (IR), whereby 1+, 2+  and
3+ were con sid ered a pos i tive al ler gic re ac tion (14).
RE SULTS
Dur ing the six-year pe riod, con tact al ler gic re ac -
tions were re corded in 4132 (2940 fe male and 1192
male) of 6341 pa tients. Anal y sis of con tact hy per -
sen si tiv ity in pa tients ac cord ing to site of skin le -
sions re vealed hands and fore arms to be the most
com monly af fected ar eas, fol lowed by the face and
neck, and to a much lesser ex tent other parts of the
body. The pa tients with pos i tive patch test re ac tions 
to the Cro atian stan dard se ries of al ler gens are pre -
sented in Ta ble 4 and Fig ure 1. The most fre quent
al ler gens were nickel sul fate, po tas sium dichroma -
te, neomycin sul fate, co balt chlo ride, carba mix and
wood tars. In 2003, the most com mon al ler gens
were nickel sul fate (43.4%), co balt chlo ride (21.7
%), po tas sium dichromate (19.3%), thimero sal
(18.8%), and neomycin sul fate (16.2%). Dur ing the
6-year pe riod of ob ser va tion, there was an in -
creased fre quency of pos i tive re ac tions to thimero -
sal (from 0.0% in 1998 to 18.8% in 2003) and neo -
mycin sul fate (from 14.6% to 16.2%), and a steadily
high positivity to po tas sium dichromate (from
16.5% to 19.3%) and nickel sul fate (from 35.4% to
43.4%) (Ta ble 4). A sig nif i cant de crease was ob -
served in the fre quency of pos i tive re ac tions to co -
balt chlo ride (from 33.1% to 21.7%), carba mix
(from 35.2% to 6.3%), wood tars (from 15.6% to
7.9%), rub ber mix ture (from 7.7% to 3.8%), de ter -
gents (from 40.8% to 7.2%), para(p-)phenyl enedi -
amine (from 6.5% to 3.9%), parabens (from 5.0% to 
2.1%), bal sam of Peru (from 10.2% to 9.1%) and
colo phony (from 2.8 % to 1.5 %). Sixty-five per cent
of the pa tients showed pos i tive re ac tions to one or
more chem i cals on patch test ing, with three al ler -
gens per pa tient on an av er age. The three most
com mon al ler gens were carba mix, co balt chlo ride
and po tas sium dichromate in male, and nickel sul -
fate, co balt chlo ride and carba mix in fe male pa -
tients. Sta tis ti cal anal y sis of three al ler gens show -
ing a ris ing fre quency dur ing the 6-year  pe riod
yielded the fol low ing val ues: po tas sium dichromate
c2=4.92, p=0.418; nickel sul fate c2=16.88,
p=0.0047; and thimerosal c2=46.98, p=0.0001. A
sta tis ti cally sig nif i cant fre quency in crease was re -
corded for nickel sul fate and thimerosal. On the
other hand, a sta tis ti cally sig nif i cant de creas ing
trend was ob served for the fre quency of co balt chlo -
ride (c2=36.87, p=0.0001), carba mix (c2=546.44,
p=0.0001) and wood tars (c2=42.77, p=0.0001).
DIS CUS SION
In con trast to the study by Bourke et al. (6), our
re sults con firmed patch test reproducibility. We
found no dis cor dance in pos i tive patch tests ac -
cord ing to age, sex, his tory of al lergy and pres ence
of mul ti ple al ler gies. The prev a lence of pos i tive
patch test re sults (65%) was sim i lar to the find ing
re ported by the North Amer i can Con tact Der ma ti tis
Group (NACDG) (66.5%) (16). The rea son for the
lower rate in our se ries is un cer tain. Many other
stud ies (14,17) have de scribed rates of pos i tive
patch test ing sim i lar to our and lower than that of
NACDG. Our find ing also un der scores the im por -
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Ta ble 3. Cro atian stan dard se ries of con tact al ler -
gens
Test substance Concentration (%) Vehicle
Potassium dichromate  0.25 petrolatum
Cobalt chloride  1.0 petrolatum
Nickel sulfate  2.5 petrolatum
Formaldehyde  1.0 water
p-Phenylenediamine  1.0 petrolatum
Balsam of Peru 25.0 petrolatum
Epoxy resin  1.0 petrolatum
Colophony 20.0 petrolatum
White mercury precipitate 10.0 petrolatum
Benzocaine (Anesthesin)  5.0 petrolatum
Carba mix  3.0 petrolatum
Mercapto mix  2.0 petrolatum
Rubber mixture (PPD mix)  0.6 petrolatum
Fragrance mix  8.0 petrolatum
Thiuram mix  1.0 petrolatum
Wood tars 12.0 petrolatum
Paraben mixture 15.0 petrolatum
Neomycin sulfate 20.0 petrolatum
Quaternium 15  2.0 petrolatum
Thimerosal  0.1 petrolatum
Detergents  2.0 water
tance of test ing for ad di tional allergens beyond a
standard tray (17).
Nickel sul fate was the most com mon al ler gen
en coun tered in our study with a mean of 39.9%,
which is in dis cor dance with other re ports rang ing
from 14.2% to 29.5% (14,16,18-20). A sim i lar high
rate (37%) was found in pa tients with pre dis po si tion 
to atopic der ma ti tis and pos i tive patch test re ac tions 
to nickel (21). Sys temic con tact der ma ti tis elic ited
nickel in all 20 pa tients in the study by Dou Xia et al.
(22). The sta tis ti cally sig nif i cantly in creased fre -
quency of nickel sul fate (p=0.0047) in our study
could be ex plained by its wide use in everyday life.
The in creased fre quency of fra grance al lergy
found in our group of pa tients (19.1%) has also
been re ported by NACDG and oth ers (13,18,21,
23,24). The pres ence of fra grances, not only in per -
fumes but also in a wide va ri ety of cos metic prod -
ucts and toi let ries con tain ing fra grances, is likely to
ac count for the in creased al lergy to fra grances.
Neomycin sul fate ac counted for 14.6% (1998) and
16.2% (2003), and sim i lar rates have been re ported 
else where (13). We found that 12.6% of our pa -
tients de vel oped al lergy to neomycin sul fate dur ing
the 6-year pe riod, which may re flect the ex tent of
the use of this top i cal an ti bi otic in the treat ment of
skin in fec tions. The in ci dence of con tact al lergy to
neomycin in 1998 was 14.6%, sim i lar to our re sults
in 2003 (16.2%) (11). Con tact al lergy to neomycin
com bined with cross-re ac tion with other aminogly -
coside an ti bi ot ics is also be com ing ever more pres -
ent (11). Bacitracin, a com monly used an ti bi otic,
showed an in creased al lergy rate (9.2%) as re -
ported by NACDG. It may cause not only de layed,
ec zem a tous con tact der ma ti tis but also an im me di -
ate re ac tion, which may re flect a de crease in the
use of bacitracin as a pro phy lac tic an ti bi otic of ten
used in sur gi cal pro ce dures. Pos i tive patch test re -
ac tions to bacitracin of ten ap pear at 96 hours. Katz
and Fisher report on bacitracin as a unique topical
antibiotic sensitizer in nine patients (25).
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Ta ble 4. Re sults of pos i tive patch test ing in 4132 pa tients 1998-2003
Year 1998 1999 2000 2001 2002 2003 Total
Positive subjects (N) 836 733 639 736 603 585 4132
Allergen n % n % n % n % n % n % n %
Potassium dichromate 138 16.5 146 19.9 106 16.6 130 17.7 103 17.1 113 19.3  736 17.8
Cobalt chloride 277 33.1 267 36.4 200 31.3 243 33.0 203 33.7 127 21.7 1317 31.9
Nickel sulfate 296 35.4 275 37.5 251 39.3 310 42.1 263 43.6 254 43.4 1649 39.9
Formaldehyde  28  3.3  10  1.4  20  3.1  13  1.8   7  1.2  13  2.2   91  2.2
p-Phenylenediamine  54  6.5  62  8.5  15  2.3  17  2.3  19  3.2  23  3.9  190  4.6
Balsam of Peru  85 10.2  99 13.5  71 11.1  78 10.6  45  7.5  53  9.1  431 10.4
Epoxy resin  39  4.7  37  5.0  13  2.0  19  2.6  14  2.3  21  3.6  143  3.5
Colophony  23  2.8  15  2.0  11  1.7   9  1.2  12  2.0   9  1.5   79  1.9
White mercury precipitate  82  9.8 104 14.2  68 10.6  78 10.6  49  8.1  62 10.6  443 10.7
Benzocaine (Anesthesin)  42  5.0  49  6.7  17  2.7  24  3.3  17  2.8  29  5.0  178  4.3
Carba mix 294 35.2 256 34.9 207 32.4  30  4.1  27  4.5  37  6.3  851 20.6
Mercapto mix  23  2.8  21  2.9  17  2.7  13  1.8   5  0.8  13  2.2   92  2.2
Rubber mixture (PPD mix)  64  7.7  55  7.5  31  4.9  43  5.8  19  3.2  22  3.8  234  5.7
Fragrance mix 182 21.8 149 20.3 102 16.0 143 19.4  96 15.9 117 20.0  789 19.1
Thiuram mix  47  5.6  43  5.9  24  3.8  21  2.9  31  5.1  24  4.1  190  4.6
Wood tars 130 15.6 130 17.7  84 13.1  85 11.5  55  9.1  46  7.9  530 12.8
Paraben mixture  42  5.0  26  3.5   7  1.1  25  3.4  10  1.7  12  2.1  122  3.0
Neomycin sulfate 122 14.6  90 12.3  63  9.9  96 13.0  56  9.3  95 16.2  522 12.6
Quaternium 15   0  0.0   9  1.2   5  0.8  13  1.8  12  2.0  11  1.9   50  1.2
Thimerosal   0  0.0  52  7.1 111 17.4 119 16.2  87 14.4 110 18.8  479 11.6
Detergents 341 40.8 140 19.1 173 27.1 128 17.4  88 14.6  42  7.2  912 22.1
Co balt chlo ride is a com mon sensitizer with a
prev a lence rate from 8.0% to 13.5% in sev eral se -
ries (13,16,18,26,27). Our pa tients showed a prev -
a lence rate of 21.7% in 2003, which is con sis tent
with most of other stud ies (13,16,26).
In our study, bal sam of Peru was also a com mon 
al ler gen dur ing the 6-year pe riod (mean 10.4%;
10.2% in 1998; 13.5% in 1999; 11.1% in 2000;
10.6% in 2001; 7.5% in 2002; and 9.1% in 2003),
which is con sis tent with the NACDG re port (13,16).
Con sis tently with other re ports (1,13,16), form al de -
hyde in duced 2.2% of pos i tive re ac tions in 2003,
how ever, pa tients with sus pected oc cu pa tional skin 
dis eases may have 4.0% of pos i tive re ac tions to
formaldehyde (19). 
Quaternuim 15 is a pre ser va tive pres ent in
many cos me tics and per sonal hy giene prod ucts.
Our find ing of 1.9% of pos i tive re ac tions to quater -
nium 15 in 2003 is in com pa ra ble to NACDG find ing
(16). A study con ducted in Tur key re ports on a 0.6% 
prev a lence of al ler gic re ac tions to quaternium 15
(26), a rate we re corded in 2000. The higher in ci -
dence ob served in our study may have re sulted
from re gional vari a tion and dif fer ence in per sonal
hab its that con trib uted to the in creased ex po sure to
quaternium 15 in our patients.
Thiuram, an im por tant oc cu pa tional al ler gen in
rub ber in dus try, caused pos i tive re ac tions in 4.1%
of our pa tients in 2003, which is con sis tent with
some re ports (19,20) but lower than the rate re -
ported by oth ers (13,16). This could be ex plained
by the fact that our pa tients are not in volved in oc cu -
pa tions that may put them at risk of ex po sure to
thiuram. The high mean rate (17.8%) of re ac tions to 
po tas sium dichromate in our study can be ex -
plained by low pre ven tive mea sures. It has been re -
ported to in duce pos i tive patch test re ac tions in
9.4% to 11.8% of cases (19,26,29). Uter et al. (28)
re port on a sig nif i cantly higher rate of al ler gic con -
tact sen si ti za tion to para amino com pounds such
as p-phenylenediamine (14.1%) than the mean rate 
ob served in our study (4.6%). The rate of al lergy to
p-phenylenediamine ob served in the pres ent study
(3.9% in 2003) was lower than the rates re ported
else where (13,16,19,28). This may have re sulted
from a de creased use of hair dyes among our pa -
tients be cause of aware ness of their al ler gic po ten -
tial. Use of al ter na tive pig ments in hair dyes may
con trib ute fur ther to the de crease of pos i tive re ac -
tions to p-phenylenediamine. Rub ber work ers and
hair dress ers are high-risk oc cu pa tional groups for
sen si ti za tion to p-phenylenediamine compounds.
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Fig ure 1: Dis tri bu tion of pos i tive patch-test re ac tion to stan dard Cro atian se ries of al ler gens in 4132 pa tients ac cord ing
to sex and al ler gens be tween 1998 and 2003. Blue bars – male; red bars – fe male.
Thimerosal is a mer cury de riv a tive used as a
pre ser va tive in var i ous prod ucts, in clud ing cos me -
tics, oph thal mic and otorhinolaryngologic med i ca -
tion, and vac cines. A lack of rel e vance of thimerosal 
re ac tions in duced by patch test ing has been re -
ported and the re ac tion may be the re sult of past ex -
po sure and vac ci na tions (30). NACDG re port on
10.4% and 10.9% of re ac tions to thimerosal
(13,16). Our find ing of 0.0%, 7.1%, 17.4%, 16.2%,
14.4% and 18.8% of re ac tions to thimerosal dur ing
the 6-year pe riod (1998-2003) of patch test ing may
be at trib ut able to the fre quent use of thimerosal as a 
pre ser va tive in cos me tics and vac cines. Pos i tive
re ac tions to the rest of patch-tested sub stances in
our study were vari ably com pa ra ble to those of
NACDG (13,16). The ICDRG, us ing a stan dard
tech nique for patch test ing, eval u ated pa tients with
sus pected al ler gic con tact der ma ti tis to detect de -
layed type contact sensitivity and to identify new al -
ler gens (29).
CON CLU SION
Our own re sults and lit er a ture data on the ever
in creas ing in ci dence of al ler gic con tact der ma ti tis
from fre quent con tact al ler gens such as nickel, co -
balt, carba mix, fra grance mix, po tas sium dichro -
ma te, thimerosal, and neomycin sul fate clearly
point to the in creas ing need of pre ven tive mea sures 
to fight this mor bid ity. The use of al ter na tive and
hid den chem i cals may re sult in an in creased fre -
quency of re ac tions to cer tain sub stances such as
thimerosal. There fore, pat terns of al ler gen fre quen -
cies can change and may raise our con cern about
emer gence of new al ler gens. We strongly rec om -
mend keep ing up-to-date with the ep i de mi ol ogy of
con tact al lergy and the re sults of patch test ing to
sub stances that may cause al ler gic contact der ma -
ti tis in patients with inflammatory dermato ses.
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